Ricardo Perdigão Henriques is the CEO of Bionova Capital. He leads the identification of new investment opportunities and the management of Hovione Capital’s portfolio companies.
Ricardo has over 15 years of experience in the life sciences sector in USA and Portugal, from biomedical research to the pharmaceutical industry. Prior to joining Bionova Capital, Ricardo was an Investment Manager at Portugal Ventures and an International Business Analyst at BIAL Labs.
Ricardo is a Harvard and MIT-educated scientist with a BSc in Biochemistry and a PhD in Molecular Oncology, with publications in high-ranking journals such as the Journal of Clinical Investigation, Oncogene (Nature Publishing Group), and Biotechnology Progress.